1.Erratum to: Dual Pathologies of Parathyroid Adenoma and Papillary Thyroid Cancer on Fluorocholine and Fluorodeoxyglucose PET/CT
N. T K THANSEER ; Sanjay Kumar BHADADA ; Ashwani SOOD ; Ashwin Singh PARIHAR ; Divya DAHIYA ; Priyanka SINGH ; Rajender Kumar BASHER ; Ashim DAS ; Bhagwant R MITTAL
Nuclear Medicine and Molecular Imaging 2018;52(1):85-85
Owing to an oversight in manuscript preparation, the name of the fifth author was rendered incorrectly. The correct spelling is Divya Dahiya.
2.Dual Pathologies of Parathyroid Adenoma and Papillary Thyroid Cancer on Fluorocholine and Fluorodeoxyglucose PET/CT
N T K THANSEER ; Sanjay Kumar BHADADA ; Ashwani SOOD ; Ashwin Singh PARIHAR ; Divya DAHIYA ; Priyanka SINGH ; Rajender Kumar BASHER ; Ashim DAS ; Bhagwant R MITTAL
Nuclear Medicine and Molecular Imaging 2018;52(2):154-158
¹â¸F-Fluorocholine (FCH) PET/CT is evolving as a functional imaging modality for the preoperative imaging of abnormal parathyroid tissue(s) helping to localize eutopic and ectopic parathyroid tissue and limit the extent of surgery. FCH PET/CT may show incidental uptake in various thyroid lesions necessitating further evaluation, whereas the role of ¹â¸F-fluorodeoxyglucose (FDG) PET/CT in the detection of incidental thyroid nodules is well documented. The case of a middle-aged woman with dual pathology of parathyroid adenoma and papillary thyroid cancer detected on FCH and FDG PET/CT is presented.
3.Erratum to: Dual Pathologies of Parathyroid Adenoma and Papillary Thyroid Cancer on Fluorocholine and Fluorodeoxyglucose PET/CT
N. T K THANSEER ; Sanjay Kumar BHADADA ; Ashwani SOOD ; Ashwin Singh PARIHAR ; Divya DAHIYA ; Priyanka SINGH ; Rajender Kumar BASHER ; Ashim DAS ; Bhagwant R MITTAL
Nuclear Medicine and Molecular Imaging 2018;52(1):85-85
Owing to an oversight in manuscript preparation, the name of the fifth author was rendered incorrectly. The correct spelling is Divya Dahiya.